Baseline characteristics, treatment dosage, and clinical outcomes of post-acute HFrEF patients initiated with Sacubitril/Valsartan
27 May 2019 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
E-Da hospital, Kaohsiung (Taiwan)
56 More presentations in this session
Access the full session
The Event
Heart Failure 2019
27 May 2019
08:30 CET
